New Key Statistics Module, Z-Score and F-Score
NAS:TVTX Key Ratios
| Market Cap $ M | 564.12 |
| Enterprise Value $ M | 527.09 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.62 |
| Price/Sales | 3.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 183.00 |
| EPS (TTM) $ | -2.10 |
| Beneish M-Score | -1.29 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -19.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.36 |
| EV-to-EBITDA | -1.52 |
| PEG | -- |
| Shares Outstanding M | 76.13 |
| Net Margin (%) | -87.94 |
| Operating Margin % | -218.39 |
| Pre-tax Margin (%) | -217.81 |
| Quick Ratio | 2.75 |
| Current Ratio | 2.78 |
| ROA % (ttm) | -21.04 |
| ROE % (ttm) | -93.65 |
| ROIC % (ttm) | -177.03 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.18 |
TVTX Number of Guru Trades
TVTX Volume of Guru Trades
Gurus Latest Trades with NAS:TVTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TVTX is held by these investors
Total 2
Travere Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TVTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers